Icure Pharmaceutical Incorporation (KOSDAQ:175250)
South Korea · Delayed Price · Currency is KRW
2,170.00
+231.00 (11.91%)
At close: Aug 5, 2025
Revenue by Segment
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| | | 16.42B | 12.96B | 13.70B | 31.19B | 42.18B | | | |
Cosmetics Division Growth | | | 26.73% | -5.47% | -56.06% | -26.05% | 145.59% | | | |
Pharmaceutical Business Division | | | 40.39B | 46.41B | 50.58B | 58.96B | 18.75B | | | |
Pharmaceutical Business Division Growth | | | -12.98% | -8.24% | -14.21% | 214.50% | 16.10% | | | |
| | | 56.81B | 59.37B | 64.28B | 90.14B | 60.92B | | | |
| | | -4.31% | -7.65% | -28.69% | 47.97% | 82.84% | | | |
Revenue by Geography
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| | | 520.11M | 1.03B | 4.54B | 5.96B | 1.62B | | | |
| | | -49.61% | -77.26% | -23.90% | 268.27% | 181.74% | | | |
| | | 56.29B | 58.33B | 59.74B | 84.18B | 59.30B | | | |
| | | -3.51% | -2.36% | -29.03% | 41.95% | 81.10% | | | |
| | | 56.81B | 59.37B | 64.28B | 90.14B | 60.92B | | | |
| | | -4.31% | -7.65% | -28.69% | 47.97% | 82.84% | | | |
Source: S&P Global Market Intelligence.
